Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment 
Molecular characterisation of Haemophilus influenzae type a and untypeable strains isolated simultaneously from cerebrospinal fluid and blood: novel use.
A. Doménech-Sánchez, C. Juan, J.L. Pérez, C.I. Berrocal 
Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
P.-Y. Lévy  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects  D. Johnsson, P. Mölling,
A. Doménech-Sánchez, C. Juan, J.L. Pérez, C.I. Berrocal 
Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment 
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR
Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection  M.
Detection of fungal DNA in lysis–centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients  L. Trovato, P. Betta, M.G.
Activity of quinupristin–dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy  A. Pantosti, F. D'Ambrosio, E. Bordi, A. Scotto d'Abusco,
M. Cogliati, R. D'Amicis, A.M. Tortorano 
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
A comparison of three real-time PCR assays for the confirmation of Neisseria gonorrhoeae following detection of N. gonorrhoeae using Roche COBAS AMPLICOR 
Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects  D. Johnsson, P. Mölling,
S. Silva, S. J. Hooper, M. Henriques, R. Oliveira, J. Azeredo, D. W
A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU  P.G. Higgins, H. Wisplinghoff, O. Krut, H.
P. Balraj, G. Vestris, D. Raoult, P. Renesto 
New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to.
Evaluation of differential gene expression in susceptible and resistant clinical isolates of Klebsiella pneumoniae by DNA microarray analysis  A. Doménech-Sánchez,
Non-antibiotic strategies for sepsis
PCR-RFLP detection and species identification of fungal pathogens in patients with febrile neutropenia  M. Dendis, R. Horváth, J. Michálek, F. Růžička,
Determination of Cryptococcus neoformans var
Rhodococcus equi pneumonia in a heart transplant recipient in Korea, with emphasis on microbial diagnosis  S.J. Yoo, H. Sung, J.D. Chae, M. -N. Kim, C.H.
Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland  D. Drudy, N. Harnedy, S. Fanning, R. O'Mahony,
Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillance  S.T. Chien,
Improved performance with saliva and urine as alternative DNA sources for malaria diagnosis by mitochondrial DNA-based PCR assays  C. Putaporntip, P.
Vector control: a cornerstone in the malaria elimination campaign
Distribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for.
PCR ribotyping and arbitrarily primed PCR for the comparison of enterotoxigenic Bacteroides fragilis strains from two Polish university hospitals  Gayane.
Spa typing directly from a mecA, spa and pvl multiplex PCR assay—a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance 
A comparison of three real-time PCR assays for the confirmation of Neisseria gonorrhoeae following detection of N. gonorrhoeae using Roche COBAS AMPLICOR 
A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V  K. Boye, M.D. Bartels, I.S. Andersen, J.A. Møller,
Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea  S.K. Niyogi,
Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection  M.
Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification  S. Lucas, M.
E. López-Camacho, Z. Rentero, G. Ruiz-Carrascoso, J. -J. Wesselink, M
Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years  T.G. Harrison, N. Doshi, N.K. Fry, C.A.
Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment 
Reena Ghildyal, Geoff Hogg, John Mills, Jayesh Meanger 
Variable flagella expression among clonal toxin A−/B+ Clostridium difficile strains with highly homogeneous flagellin genes  H. Pituch, P. Obuch-Woszczatyñski,
S.-M. Sheu, B.-S. Sheu, C.-C. Lu, H.-B. Yang, J.-J. Wu 
Volume 54, Issue 2, Pages (August 1998)
R. Alonso, C. Muñoz, T. Peláez, E. Cercenado, M. Rodríguez-Creixems, E
Update on antifungal resistance in Aspergillus and Candida
A. Gelosia, L. Baldassarri, M. Deighton, T. van Nguyen 
The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive.
S.B. Schwartz, K.A. Thurman, S.L. Mitchell, B.J. Wolff, J.M. Winchell 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Rebecca J. Seward, Kevin J. Towner  Clinical Microbiology and Infection 
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae  I. Gustafsson, O. Cars  Clinical Microbiology.
Pyrosequencing for rapid identification of carbapenem-hydrolysing OXA-type β- lactamases in Acinetobacter baumannii  T. Naas, L. Poirel, P. Nordmann  Clinical.
Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii 
B. Bakhshi, M.R. Pourshafie, F. Navabakbar, A. Tavakoli 
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release  J. SjöUlin,
Tohru Umekawa, Nasser Chegini, Saeed R. Khan, Ph.D. 
B. Govan, N. Ketheesan  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
Typing of Clostridium difficile
Impact of antibiotic restrictions: the patient's perspective
Combination of pulsed-field gel electrophoresis (PFGE) and single-enzyme amplified fragment length polymorphism (SAFLP) for differentiation of multiresistant.
The future of diagnostic bacteriology
Presentation transcript:

Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility  S-J. Liaw, H-C. Wu  Clinical Microbiology and Infection  Volume 16, Issue 6, Pages 696-703 (June 2010) DOI: 10.1111/j.1469-0691.2009.02930.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 (a) Agarose gel electrophoresis of the CAP59 gene restriction profiles of Cryptococcus neoformans serotypes. Upper panel, BsmFIrestricted profile; lower panel, HpaII-restricted profile. C1--C4, serotype A clinical isolates; E1-E4, environmental isolates; CB, serotype B clinical isolate; A, ATCC 90112, serotype A; B, ATCC 32269, serotype B; D, ATCC 34873, serotype D; M, 100-bp marker. (b) Amplified fragments of isolates obtained in multiplex PCR with the primers for LAC1 and CAP64. C1-C6, serotype A clinical isolates; A, B, D and M are as in (a) Clinical Microbiology and Infection 2010 16, 696-703DOI: (10.1111/j.1469-0691.2009.02930.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 (a) Examples of URA5 gene restriction fragment profiles of clinical and environmental isolates of Cryptococcus neoformans. C6-C7, C9 and CB, clinical isolates; E5-E6, environmental isolates; A, B, D, and M are as in Fig. 1. (b) Examples of PCR fingerprinting patterns obtained with the primer M13. C9, C31-C32, clinical isolates of C. neoformans; A, B, D, and M are as in Fig. 1. (c) Examples of PCR fingerprinting patterns obtained with the primer (GACA)4. C31-32, clinical isolates; E1-E4, A, B, D, M are as in Fig.1; C, ATCC 32608, serotype C. Clinical Microbiology and Infection 2010 16, 696-703DOI: (10.1111/j.1469-0691.2009.02930.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Adhesion of phospholipase-producing Cryptococcus neoformans to A549 cells. (a) C24, 42, 45, low producers; C52, 59, 95, high producers; E7, 8, environmental isolates. The Pz value is shown above each bar. Results obtained for C59 cells were defined as 100%. The data are averages and standard deviations of three independent experiments. a, b significantly different from c (p <0.01, by Student's t test). (b) Lactate dehydrogenase (LDH) release of A549 cells after interaction with phospholipase-producing C. neoformans. C24, 42, 45, 52, 59, 95, E7-8, are as in (a). Supernatants, after incubation, were assayed for LDH release using colorimetry described in Materials and Methods. Data are expressed as a percentage of LDH release from unstimulated cells treated with Triton X-100 and represent the mean ± SD of triplicate measurements from two independent experiments. Control, medium only background. a vs. b, p <0.01 by Student's t test. (c) Light microscopy of C. neoformans adhering to A549 cells. A549 cells were stimulated for 6 h at 37°C with low (C24) or high (C59) phospholipase-producing isolates of C. neoformans, followed by washing, trypsinization, cytospin to slides and observation. a, no yeast control, 400×; b, A549 incubated with C59, 400×; c, A549 incubated with C24, 400×; d, A549 incubated with C59, 650×. Data are representative of three independent experiments. Clinical Microbiology and Infection 2010 16, 696-703DOI: (10.1111/j.1469-0691.2009.02930.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 4 Amphotericin B killing assay of melanized and non-melanized Cryptococcus neoformans. The survival rates of melanized vs. non-melanized yeast cells (clinical isolates, C48 and C67) after exposure to 0.25 and 0.5 mg/L of amphotericin B for 2 h were compared with those of fungal cells incubated in phosphate-buffered saline. The data represent averages of four independent experiments with standard deviations. p <0.05 as determined by Student's t test for a comparison between non-melanized and melanized cells. Clinical Microbiology and Infection 2010 16, 696-703DOI: (10.1111/j.1469-0691.2009.02930.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions